Moreover, modafinil has been recently demonstrated to act as a cellular‐coupling enhancer in astrocytes, through the modulation of gap junctions constituted by connexins.18 In particular, astroglial connexins are involved in sleep and homeostasis regulation,18, 19 as sleep deprivation and subsequent sleep rebound modify their expression and their inhibition causes sleep loss,20, 21 and are more largely involved in neuronal modulation.22 In addition, an astroglial connexin modulator, flecainide,23 has been shown to significantly enhance the wake‐promoting and procognitive effects of modafinil in nonclinical models.24 Modafinil effects on astroglial cell coupling mediated by connexin 30 were reversed by flecainide.24 Altogether, these results indicate that low‐dose flecainide improved the wake‐promoting and procognitive functions of modafinil, probably through the changes of connexin‐dependent gap junctional coupling in astroglial networks. Non‐clinical studies in rat indicated that THN102 significantly increased regional brain
glucose metabolism in the cortex, striatum and amygdala compared to control or drugs administered alone.25
The present study aims to evaluate the effect of the combination of modafinil and flecainide low dose, namely THN102, as a clinical proof of concept of its efficacy on vigilance and cognition
I was going down a rabbit hole related to new Orexin agonist clinical trials and came across this… anyone know if it also works on any other stimulant?